Krsnaa Diagnostics (NSE:KRSNAA) Marketable Securities: ₹3,618 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
71 GF Score
Price ₹556.75
GF Value ₹931.56
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics Marketable Securities?

Krsnaa Diagnostics NSE:KRSNAA -2.96% 71 Marketable Securities is ₹3,618 Mil as of Mar. 2026. GuruFocus rates NSE:KRSNAA with a GF Score™ of 71/100 and a GF Value™ of ₹931.56 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Krsnaa Diagnostics's Marketable Securities for the quarter that ended in Mar. 2026 was ₹3,618 Mil.

Krsnaa Diagnostics's annual Marketable Securities declined from Mar. 2024 (₹1,728 Mil) to Mar. 2025 (₹646 Mil) but then increased from Mar. 2025 (₹646 Mil) to Mar. 2026 (₹3,618 Mil).

Krsnaa Diagnostics  (NSE:KRSNAA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Krsnaa Diagnostics Marketable Securities Related Terms

Krsnaa Diagnostics Marketable Securities Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Marketable Securities Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 1,534.28 860.76 1,728.10 645.90 3,618.15

Krsnaa Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 645.90 0.00 1,491.47 0.00 3,618.15
NSE:KRSNAA
71GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krsnaa Diagnostics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹3,618 Mil mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a Marketable Securities of ₹3,618 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Krsnaa Diagnostics and its competitors.
Is Krsnaa Diagnostics' Marketable Securities too high?
Krsnaa Diagnostics' current Marketable Securities is ₹3,618 Mil. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Marketable Securities compare to TMO and DHR?
Krsnaa Diagnostics' Marketable Securities of ₹3,618 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Krsnaa Diagnostics and its competitors. Krsnaa Diagnostics's current Marketable Securities is ₹3,618 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹931.56, compared to a current price of ₹556.75 — trading 40.2% below its estimated fair value. The current Marketable Securities is ₹3,618 Mil. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Marketable Securities is ₹3,618 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹556.75 is trading 40.2% below its estimated GF Value™ of ₹931.56. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • Marketable Securities: ₹3,618 Mil
  • GF Value™: ₹931.56 vs. price of ₹556.75 (40.2% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score

Get the complete analysis for NSE:KRSNAA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹556.75
Price
₹931.56
GF Value